ANTIMYOCLONIC ACTION OF PIRACETAM

被引：28

作者：

OBESO, JA

ARTIEDA, J

LUQUIN, MR

VAAMONDE, J

LAGE, JMM

机构：

来源：

CLINICAL NEUROPHARMACOLOGY | 1986年 / 9卷 / 01期

关键词：

D O I：

10.1097/00002826-198602000-00006

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：58 / 64

页数：7

共 22 条

[1]

[Anonymous], 1982, MOVEMENT DISORD

[2] CLINICAL, BIOCHEMICAL, AND PHYSIOLOGICAL FEATURES DISTINGUISHING MYOCLONUS RESPONSIVE TO 5-HYDROXYTRYPTOPHAN, TRYPTOPHAN WITH A MONOAMINE-OXIDASE INHIBITOR, AND CLONAZEPAM [J].

CHADWICK, D ;

HALLETT, M ;

HARRIS, R ;

JENNER, P ;

REYNOLDS, EH ;

MARSDEN, CD .

BRAIN, 1977, 100 (SEP) :455-487

[3]

CREMIEUX C, 1979, NOUV PRESSE MED, V41, P3357

[4] ESSENTIAL MYOCLONUS - RESPONSE TO ANTICHOLINERGIC THERAPY [J].

DUVOISIN, RC .

CLINICAL NEUROPHARMACOLOGY, 1984, 7 (02) :141-147

[5]

Fahn S, 1979, Adv Neurol, V26, P49

[6]

Fahn S, 1986, Adv Neurol, V43, P197

[7]

FAHN S, 1985, MYOCLONUS

[8]

FRIEDMAN E, 1981, NEW ENGL J MED, V304, P1490

[9] INTENTION MYOCLONUS - SUCCESSFUL TREATMENT WITH CLONAZEPAM [J].

GOLDBERG, MA ;

DORMAN, JD .

NEUROLOGY, 1976, 26 (01) :24-26

[10]

ILIVAINEN M, 1982, ARCH NEUROL, V39, P236

← 1 2 3 →